Peer review Peer review information Nature thanks Dipender Gill, Ruth Loos and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
It focused on individual-level randomized clinical trial (RCT) data of GLP1-RA from the HARMONY program [Liraglutide (389 individuals) and Albiglutide (1,682 individuals)], the PRIBA study [Liraglutide (397 individuals), exenatide (223 individuals), and Tayside & Fife (415 individuals)
Feeling hungry all the time
Imapextide (MBX 1416), long-acting GLP-1 receptor antagonist for post-bariatric hypoglycemia (PBH)
He holds a Bachelor of Commerce in Marketing and Finance from Toronto Metropolitan University and focuses on SEO-driven health and financial education that helps Canadians navigate modern healthcare and payment decisions.
The results showed that none of the GLP-1RAs showed possible drug interactions with neuropsychiatric drugs